ASP8232

ASP8232 · Astellas Pharma Europe B.V.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ASP8232, covering 2024-10-31 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME) [Phase 2]

See pricing